We have data on 78 companies that use SAS/QC Software. The companies using SAS/QC Software are most often found in United States and in the Pharmaceuticals industry. SAS/QC Software is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SAS/QC Software usage goes back as far as 5 years and 6 months.
|Company||Catholic Health Initiatives|
|Company||Huntington Ingalls Industries, Inc.|
|Catholic Health Initiatives||catholichealthinitiatives.org||United States||>1000M||1000-5000|
|Huntington Ingalls Industries, Inc.||huntingtoningalls.com||United States||>1000M||>10000|
|SuccessFactors, Inc.||successfactors.com||United States||200M-1000M||1000-5000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Analytics. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Analytics category, SAS/QC Software has a market share of about 0.1%. Other major and competing products in this category include:
SAS/QC software provides a comprehensive set of tools for statistical quality improvement and design of experiments. You can use these tools to organize quality improvement efforts, design and analyze experiments for process discovery and optimization, apply Taguchi methods for quality engineering, establish statistical control of a process, maintain statistical control and reduce variation, assess process capability, and analyze product reliability.
Looking at SAS/QC Software customers by industry, we find that Pharmaceuticals (23%), Computer Software (16%) and Hospital & Health Care (10%) are the largest segments.
68% of SAS/QC Software customers are in United States and 7% are in India.
Of all the customers that are using SAS/QC Software, a majority (70%) are large (>1000 employees), 11% are small (<50 employees) and 7% are medium-sized.
Of all the customers that are using SAS/QC Software, a majority (68%) are large (>$1000M), 11% are small (<$50M) and 0% are medium-sized.